Regeneron Pharmaceuticals (Nasdaq: REGN) is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
Recent Mentions on Fool.com
- Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri
- 7 Things Regeneron Pharmaceuticals Inc.'s Management Wants You to Know
- 3 Stocks That Soared Stupendously This Week
- Why 3D Systems, Arista Networks, and Regeneron Pharmaceuticals Jumped Today
- General Electric Falls as the Dow Drops Back